Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

White House Unveils COVID-19 Vaccine Distribution Plan for Children Ages 5 to 11 Upon Approval

10/20/2021 | 04:11pm EST


ę MT Newswires 2021
All news about PFIZER, INC.
04:36pGSK And Pfizer Hold Out For 60 Bln Stg Bid For Consumer Health Unit - FT
RE
04:33pGsk and pfizer hold out for ú60bn bid for consumer health unit - ft
RE
07:44aOMICRON-SPECIFIC VACCINE LIKELY TO C : Sharma
AQ
07:23aIndonesia to introduce new tax breaks on property, car sales
RE
01/15GSK rejects $68b Unilever bid for consumer healthcare unit
AQ
01/15Factbox-GSK's consumer health business
RE
01/15GSK rejects 50-billion-pound Unilever offer for consumer assets
RE
01/14U.S. FDA approves drugs from AbbVie, Pfizer to treat eczema
RE
01/14U.S. FDA approves Pfizer's drug to treat eczema
RE
01/14FDA Approves Pfizer's CIBNOQ For Adults With Moderate-to-Severe Atopic Dermatitis
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 916 M - -
Net income 2021 22 210 M - -
Net Debt 2021 27 661 M - -
P/E ratio 2021 14,4x
Yield 2021 2,88%
Capitalization 308 B 308 B -
EV / Sales 2021 4,10x
EV / Sales 2022 3,31x
Nbr of Employees 78 500
Free-Float -
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 54,95 $
Average target price 57,10 $
Spread / Average Target 3,90%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-6.94%308 427
JOHNSON & JOHNSON-1.35%441 855
ROCHE HOLDING AG-3.72%323 901
ABBVIE INC.0.35%240 202
ELI LILLY AND COMPANY-11.62%221 317
NOVO NORDISK A/S-15.01%218 444